Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

GlaxoSmithKline PLC

+ Add to Watchlist

GLAXF:US

23.7700 USD 0.5200 2.24%

As of 20:10:00 ET on 03/27/2015.

Snapshot for GlaxoSmithKline PLC (GLAXF)

Open: 23.5150 Day's Range: 23.5150 - 23.7700 Volume: 1,907
Previous Close: 23.2500 52wk Range: 20.5000 - 28.4500 1-Yr Rtn: -7.85%

Stock Chart for GLAXF

No chart data available.
  • GLAXF:US 23.7700
  • 1D
  • 1M
  • 1Y
23.2500
Interactive GLAXF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GLAXF

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 17.6709
Relative P/E vs. SPX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (12/2015) 0.9040
Est. PEG Ratio 4.9679
Market Cap (M USD) 115,637.16
Shares Outstanding (M) 4,864.84
30 Day Average Volume 2,436
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 6.05%
Cash Dividend (GBp) 23.0000
Dividend Ex-Date 02/19/2015
5 Year Dividend Growth 6.03%
Next Earnings Announcement 05/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GLAXF

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for GLAXF

GlaxoSmithKline PLC is a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart & circulatory disease, and cancer.

Andrew WittyChief Executive OfficerSimon P DingemansChief Financial Officer
David RedfernChief Strategy OfficerMoncef SlaouiChairman:Vaccines
More Company Profile & Key Executives for GLAXF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil